QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
27.77
+2.04 (7.93%)
Apr 24, 2025, 4:00 PM EDT - Market closed
QuidelOrtho Market Cap
QuidelOrtho has a market cap or net worth of $1.87 billion as of April 24, 2025. Its market cap has decreased by -35.34% in one year.
Market Cap
1.87B
Enterprise Value
4.46B
1-Year Change
-35.34%
Ranking
Category
Stock Price
$27.77
Market Cap Chart
Since December 1, 1998, QuidelOrtho's market cap has increased from $50.50M to $1.87B, an increase of 3,610.67%. That is a compound annual growth rate of 14.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 1.74B | -42.08% |
Dec 31, 2024 | 3.00B | -39.16% |
Dec 29, 2023 | 4.92B | -12.97% |
Dec 30, 2022 | 5.66B | 0.58% |
Dec 31, 2021 | 5.63B | -25.56% |
Dec 31, 2020 | 7.56B | 141.82% |
Dec 31, 2019 | 3.13B | 62.74% |
Dec 31, 2018 | 1.92B | 30.30% |
Dec 29, 2017 | 1.47B | 110.78% |
Dec 30, 2016 | 699.20M | -0.82% |
Dec 31, 2015 | 705.00M | -29.16% |
Dec 31, 2014 | 995.20M | -5.10% |
Dec 31, 2013 | 1.05B | 69.58% |
Dec 31, 2012 | 618.40M | 22.92% |
Dec 30, 2011 | 503.10M | 22.14% |
Dec 31, 2010 | 411.90M | -0.84% |
Dec 31, 2009 | 415.40M | -2.35% |
Dec 31, 2008 | 425.40M | -33.14% |
Dec 31, 2007 | 636.30M | 39.94% |
Dec 29, 2006 | 454.70M | 28.37% |
Dec 30, 2005 | 354.20M | 120.00% |
Dec 31, 2004 | 161.00M | -48.86% |
Dec 31, 2003 | 314.80M | 214.17% |
Dec 31, 2002 | 100.20M | -54.14% |
Dec 31, 2001 | 218.50M | 74.94% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 771.21B |
UnitedHealth Group | 387.31B |
Johnson & Johnson | 372.94B |
AbbVie | 319.23B |
Novo Nordisk | 276.96B |
Abbott Laboratories | 225.22B |
AstraZeneca | 213.42B |
Novartis AG | 208.99B |